相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term remission of primary cutaneous neutrophil-rich CD30+anaplastic large cell lymphoma treated with topical imiquimod. A case report
D. Calista et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Smad2 and Smad3 Inversely Regulate TGF-β Autoinduction in Clostridium butyricum-Activated Dendritic Cells
Ikkou Kashiwagi et al.
IMMUNITY (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients
Timothy P. Cripe et al.
MOLECULAR THERAPY (2015)
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma
Arne Kolstad et al.
BLOOD (2015)
The Human Agonistic CD40 Antibody ADC-1013 Eradicates Bladder Tumors and Generates T-cell-Dependent Tumor Immunity
Sara M. Mangsbo et al.
CLINICAL CANCER RESEARCH (2015)
Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression
Alba Rodriguez-Garcia et al.
CLINICAL CANCER RESEARCH (2015)
Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft
Gewen Tan et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers
T. Du et al.
CANCER GENE THERAPY (2014)
Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte-macrophage colony-stimulating factor for murine ovarian cancer
Fumi Goshima et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Imiquimod in the Treatment of Breast Cancer Skin Metastasis
Lisa Henriques et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
Manisha Singh et al.
JOURNAL OF IMMUNOLOGY (2014)
CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
Christine E. Engeland et al.
MOLECULAR THERAPY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Systemic CD8+ T Cell-Mediated Tumoricidal Effects by Intratumoral Treatment of Oncolytic Herpes Simplex Virus with the Agonistic Monoclonal Antibody for Murine Glucocorticoid-Induced Tumor Necrosis Factor Receptor
Mikiya Ishihara et al.
PLOS ONE (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
Nicholas J. Roberts et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines
Romain Banchereau et al.
NATURE COMMUNICATIONS (2014)
Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial
Andres M. Salazar et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585]
Nina Bhardwaj et al.
Journal for ImmunoTherapy of Cancer (2014)
Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model
Darren Shafren et al.
Journal for ImmunoTherapy of Cancer (2014)
Oncolytic Adenoviruses in Cancer Treatment
Ramon Alemany
BIOMEDICINES (2014)
Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
Simon J. Dovedi et al.
BLOOD (2013)
Enhancement of systemic tumor immunity for squamous cell carcinoma cells by an oncolytic herpes simplex virus
N. Meshii et al.
CANCER GENE THERAPY (2013)
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
Caroline J. Breitbach et al.
CANCER RESEARCH (2013)
Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell-Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
Marieke F. Fransen et al.
CLINICAL CANCER RESEARCH (2013)
Agonistic CD40 Antibodies and Cancer Therapy
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2013)
Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model
Carina Riediger et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
Aurelien Marabelle et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell-mediated glioma rejection
Johannes vom Berg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Oncolytic viruses as therapeutic cancer vaccines
David L. Bartlett et al.
MOLECULAR CANCER (2013)
The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
Diana M. Rommelfanger et al.
MOLECULAR THERAPY (2013)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo et al.
NATURE MEDICINE (2013)
Synergistic antitumor effect of JAWSII dendritic cells and interleukin 12 in a melanoma mouse model
Lukasz Zapala et al.
ONCOLOGY REPORTS (2013)
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
Caroline J. Voskens et al.
PLOS ONE (2013)
Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
Tooba A. Cheema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
Wei Zhang et al.
NEOPLASIA (2013)
TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+ head and neck cancer cells
Chwee Ming Lim et al.
ONCOIMMUNOLOGY (2013)
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
Youn H. Kim et al.
BLOOD (2012)
Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer
T. T. Sahin et al.
CANCER GENE THERAPY (2012)
Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy
J. Conner et al.
CANCER GENE THERAPY (2012)
Hyaluronan Synthase HAS2 Promotes Tumor Progression in Bone by Stimulating the Interaction of Breast Cancer Stem-Like Cells with Macrophages and Stromal Cells
Hiroshi Okuda et al.
CANCER RESEARCH (2012)
Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
Iulia Diaconu et al.
CANCER RESEARCH (2012)
Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients
Sari Pesonen et al.
CANCER RESEARCH (2012)
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
Sylvia Adams et al.
CLINICAL CANCER RESEARCH (2012)
Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
M. Zahidunnabi Dewan et al.
CLINICAL CANCER RESEARCH (2012)
Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors
Rong Fan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance
Vincenzo Cerullo et al.
MOLECULAR THERAPY (2012)
The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
Kelley A. Parato et al.
MOLECULAR THERAPY (2012)
An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
Huagang Zhang et al.
PLOS ONE (2012)
A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer
A. Nakao et al.
CANCER GENE THERAPY (2011)
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
Sally M. Amos et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines
Sebastian Kreiter et al.
CANCER RESEARCH (2011)
Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
Marieke F. Fransen et al.
CLINICAL CANCER RESEARCH (2011)
Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses
Meghan B. Davis et al.
CLINICAL CANCER RESEARCH (2011)
Treatment of Locally Recurrent Mucosal Melanoma With Topical Imiquimod
Elizabeth C. Smyth et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
Stephen J. Schuster et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus
Vincenzo Cerullo et al.
MOLECULAR THERAPY (2011)
A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
Tae-Ho Hwang et al.
MOLECULAR THERAPY (2011)
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Caroline J. Breitbach et al.
NATURE (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
High Response Rate After Intratumoral Treatment With Interleukin-2 Results From a Phase 2 Study in 51 Patients With Metastasized Melanoma
Benjamin Weide et al.
CANCER (2010)
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners
Xinmei Zhu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
Kevin J. Harrington et al.
CLINICAL CANCER RESEARCH (2010)
Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer
K. Anwer et al.
GENE THERAPY (2010)
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Joshua D. Brody et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Cheng Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Potentiating Cancer Immunotherapy Using an Oncolytic Virus
Byram W. Bridle et al.
MOLECULAR THERAPY (2010)
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
Alexandre Carpentier et al.
NEURO-ONCOLOGY (2010)
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma†
Myrna R. Rosenfeld et al.
NEURO-ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation
Chao-Yi Wu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors
Joshua D. Brody et al.
BLOOD (2009)
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
Massimo Di Nicola et al.
BLOOD (2009)
T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
Roch Houot et al.
BLOOD (2009)
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
Claire Banissi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients
J-L Li et al.
GENE THERAPY (2009)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil N. Senzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Regression of Established AB1 Murine Mesothelioma Induced by Peritumoral Injections of CpG Oligodeoxynucleotide Either Alone or in Combination with Poly(I:C) and CD40 Ligand Plasmid DNA
Geoffrey W. Stone et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Systemic effects of local radiotherapy
Silvia C. Formenti et al.
LANCET ONCOLOGY (2009)
Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
Byram W. Bridle et al.
MOLECULAR THERAPY (2009)
Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma
Geoffrey W. Stone et al.
PLOS ONE (2009)
The role of CD40 and CD154/CD40L in dendritic cells
Daphne Y. Ma et al.
SEMINARS IN IMMUNOLOGY (2009)
Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation
Fabian Benencia et al.
CANCER BIOLOGY & THERAPY (2008)
Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity
Andrew D. Simmons et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
LPS/TLR4 signal transduction pathway
Yong-Chen Lu et al.
CYTOKINE (2008)
Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity
Zahari Raykov et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas
Oliver M. Grauer et al.
JOURNAL OF IMMUNOLOGY (2008)
Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo
Daniel M. Appledorn et al.
JOURNAL OF IMMUNOLOGY (2008)
An adjuvant autologous therapeutic vaccine (HSPPC-96 vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentrel, open-label, randomised phase III trial
Christopher Wood et al.
LANCET (2008)
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
Byeong-Ho Park et al.
LANCET ONCOLOGY (2008)
Primary cutaneous follicle center lymphoma associated with alopecia areata
Heather M. Richmond et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged
Sanjay Sharma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas
Christopher L. Mariani et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU
Sheng Hou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself
Jiali Li et al.
JOURNAL OF IMMUNOLOGY (2007)
Intratumoral injection of IL-12 plasmid DNA - results of a phase I/IB clinical trial
D. M. Mahvi et al.
CANCER GENE THERAPY (2007)
Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses
Sebastian Tuve et al.
CANCER RESEARCH (2007)
Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
Jun Guo et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways
Jiangao Zhu et al.
JOURNAL OF VIROLOGY (2007)
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
Xinmei Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod
A. Stavrakoglou et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Steady-state and inflammatory dendritic-cell development
Ken Shortman et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Inhibitory effect of the polyinosinic-polycytidylic acid/cationic liposome on the progression of murine B16F10 melanoma
Taku Fujimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor
Jennifer C. C. Hu et al.
CLINICAL CANCER RESEARCH (2006)
Treatment of mycosis fungoides with imiquimod 5% cream
N. Ariffin et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
Young-Sook Lee et al.
CLINICAL CANCER RESEARCH (2006)
Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF
J. H. Kim et al.
MOLECULAR THERAPY (2006)
Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancer
Hideto Kimata et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect
K-J Choi et al.
GENE THERAPY (2006)
The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu
Mohamed L. Salem et al.
VACCINE (2006)
Essential role of mda-5 in type IIFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus
Leonid Gitlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy
H Saji et al.
CLINICAL CANCER RESEARCH (2006)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers
S Varghese et al.
CANCER GENE THERAPY (2006)
Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy
Y Ino et al.
CLINICAL CANCER RESEARCH (2006)
Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system
H Fukuhara et al.
CANCER RESEARCH (2005)
HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer
F Benencia et al.
MOLECULAR THERAPY (2005)
Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells
WR Song et al.
CANCER RESEARCH (2005)
Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the toll-like receptor-7/8 agonist, imiquimod
DE Spaner et al.
LEUKEMIA & LYMPHOMA (2005)
Defining the antigen-specific T-Cell response to vaccination and poly(I:C)/TLR3 signaling -: Evidence of enhanced primary and memory CD8 T-Cell responses and antitumor immunity
ML Salem et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Microwave tumour coagulation plus in situ treatment with cytokine-microparticles:: Induction of potent anti-residual tumour immunity
M Kuang et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2005)
B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides
B Jahrsdorfer et al.
CLINICAL CANCER RESEARCH (2005)
Treatment of patch and plaque stage mycosis fungoides with imiuquimod 5% cream
MJ Deeths et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
B Sangro et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Induction of potent antitumor immunity by in situ targeting of intraturnoral DCs
K Furumoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Dendritic cells in vaccination therapies of human malignant disease
VL Reichardt et al.
BLOOD REVIEWS (2004)
Bacteriolytic therapy can generate a potent immune response against experimental tumors
N Agrawal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Primary cutaneous CD30+T-cell lymphoma responsive to topical imiquimod (Aldara®)
B Didona et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature:: A novel mechanism for IL-21
C Jackaman et al.
JOURNAL OF IMMUNOLOGY (2003)
Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases
P Radny et al.
BRITISH JOURNAL OF CANCER (2003)
TRAF6 is a critical factor for dendritic cell maturation and development
T Kobayashi et al.
IMMUNITY (2003)
The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells
E Bourke et al.
BLOOD (2003)
Analysis of the antitumoral mechanisms of lipopolysaccharide against glioblastoma multiforme
EK Won et al.
ANTI-CANCER DRUGS (2003)
Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type IIFN synthesis in human plasmacytoid dendritic cells
M Kerkmann et al.
JOURNAL OF IMMUNOLOGY (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides
R Dummer et al.
DERMATOLOGY (2003)
Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells
E Noessner et al.
JOURNAL OF IMMUNOLOGY (2002)
Treatment of stage IA cutaneous T-cell lymphoma with topical application of the immune response modifier imiquimod
KR Suchin et al.
ARCHIVES OF DERMATOLOGY (2002)
Mobilization of dendritic cell precursors in patients with cancer by Flt3 ligand allows the generation of higher yields of cultured dendritic cells
CE Marroquin et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study
V Papanastassiou et al.
GENE THERAPY (2002)
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
JM Timmerman et al.
BLOOD (2002)
In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2
ME Neville et al.
CYTOKINE (2001)
Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory
M Suresh et al.
JOURNAL OF IMMUNOLOGY (2001)
Perilesional injection cutaneous melanoma of r-GM-CSF in patients with metastases
C Hoeller et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer
JJ Bennett et al.
ANNALS OF SURGERY (2001)
Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA:: Induction of CD8+ T-cell immunity and NK activity
P Slos et al.
CANCER GENE THERAPY (2001)
In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice
AB Pawlowska et al.
BLOOD (2001)
Intratumoral injection of lipopolysaccharide causes regression of subcutaneously implanted mouse glioblastoma multiforme
MR Chicoine et al.
NEUROSURGERY (2001)
Intralesional injection of herpes simplex virus 1716 in metastatic melanoma
RM MacKie et al.
LANCET (2001)
Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer
MA Morse et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis
H Singh-Jasuja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex
DMJ Hoffman et al.
WORLD JOURNAL OF UROLOGY (2000)
Functional responses and costimulator dependence of memory CD4(+) T cells
CA London et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
